An observational study in Cystic Fibrosis, sponsored by Elif Kabasakal. Completed at 1 site in Turkey. Open to participants aged 16 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-01-18.
Sponsored by Elif Kabasakal · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 49 studies in Cystic Fibrosis with a site in Turkey — 4 open to participants now, 4 under way, none of them phase 3. Cystic Fibrosis · Turkey.
Among the 49 studies in Cystic Fibrosis with a site in Turkey, this one has the largest enrollment of the 27 observational ones that give a count, is one of 9 that started in 2021, is one of 27 observational ones, and was the 24th registered.
1,622 studies on the registry are indexed under Cystic Fibrosis; 201 are open to participants now.
Browse Cystic Fibrosis studies →4 of the 49 studies in Cystic Fibrosis with a site in Turkey are open now. Recruiting first, the newest first:
Izmir Democracy University · Sites in Turkey
Ages 6–18
Hacettepe University · Sites in Turkey
Ages 8–18
Hacettepe University · Sites in Turkey
Ages 18–45 · Healthy volunteers
büşra başpınar · Sites in Turkey
Ages 6–18
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 156 Cystic Fibrosis studies recruiting now, 95 (61%) set no upper age limit and 45 (29%) stop at 75 or younger; 87 take children under 18; 42 take healthy volunteers.
This study: 16 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
49 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 9 started in 2021.
This study's enrollment of 128 is above the median of 86 across 504 observational studies indexed under Cystic Fibrosis.
Median enrollment 35 across the 22 interventional studies, 50 across the 27 observational. Of the 42 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 49 have an industry lead sponsor. The 10 most frequent:
Elif Kabasakal is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Elif Kabasakal has 1 study filed under Cystic Fibrosis — fewer than ten, so there is no comparison to draw.
2 of the studies in Cystic Fibrosis with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06984679Izmir Democracy UniversityPhysical Impairments in Children With Cystic Fibrosis | 2027-03-01 |
| NCT07930221Hacettepe UniversityThe Effects of Yoga Practice on Exercise Capacity, Arterial Stiffness, Respiratory Function, Peripheral Muscle Strength, Posture and Quality of Life in Children With Cystic Fibrosis | 2027-07 |
Add all 2 to your calendar (.ics) → With an account.
Among the 49 studies in Cystic Fibrosis with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study; The COVID-19 pandemic is to investigate the effects of COVID-19 fear levels of patients with cystic fibrosis on the psychosocial and quality of life levels of individuals.
After individuals were informed about the study, it was administered to individuals who gave written informed consent.This study was carried out on individuals with cystic fibrosis and healthy individuals who meet the eligibility requirements, through online forms.
64 individuals with cystic fibrosis and 70 healthy individuals participated in the study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: Survey Form, The Hospital Anxiety and Depression Scale, The Fear of COVID-19 Scale,World Health Organization Quality of Life Scale- Bref Form
Behavioral: Survey Form, The Hospital Anxiety and Depression Scale, The Fear of COVID-19 Scale,World Health Organization Quality of Life Scale- Bref Form
Online questionnaires were administered to individuals.
fear of covid-19
COVID-19 Fear Scale: This scale is a one-dimensional instrument consisting of seven items with robust psychometric properties that measure fear of COVID-19. It has a 5-point Likert-type rating system (1: Strongly disagree, 5: Strongly agree). It is reliable and valid in assessing fear of COVID-19 among the general population. Turkish validity and reliability of the scale were ensured.
Time frame: November- December/2021
psychosocial factors
Hospital Anxiety and Depression Scale (HADS): The scale consists of 14 items. 7 of these items measure anxiety and 7 of them measure depression symptoms. The items in the scale are evaluated with a 4-point Likert scale and are based on a scoring system between 0-3.
Time frame: November-December/2021November-December/2021
quality of life assessment
It is an internationally comparable assessment tool developed by the World Health Organization. The scale evaluates the level of quality of life. The scale consists of 26 items. The Turkish version of WHOQOL-Bref consists of 27 items. Question 27 has been added to the Turkish version of the scale as a national environmental field and is used only in national studies. The scale includes the areas of physical health, psychological health, social relations, environment and national environment. It has a 5-point likert-type rating system. The score of each area is important on its own. Higher scores in each area indicate better quality of life. The first two questions of the quality of life scale are not included in the scoring and are evaluated separately. The number of questions, which was 26 in the original of the scale, is used as 27 in the Turkish version.
Time frame: November-December/2021November-December/2021
Plan to share: No
No publications or documents are linked to this record.
Ran from Nov 2021 to primary completion in Nov 2021, 0 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Elif Kabasakal